ArriVent BioPharma, Inc. AVBP Other operating expenses
Other operating expenses at other companies
Other financials
Where this comes from
Reported directly by ArriVent BioPharma, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The official record: ArriVent BioPharma, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about ArriVent BioPharma, Inc.'s other operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ArriVent BioPharma, Inc.'s other operating expenses?
- ArriVent BioPharma, Inc. (AVBP) reported other operating expenses of $46.11M in Q1 2026.
- How has ArriVent BioPharma, Inc.'s other operating expenses changed year-over-year?
- ArriVent BioPharma, Inc.'s other operating expenses decreased by 30.9% year-over-year, from $66.77M to $46.11M.
- What is the long-term trend for ArriVent BioPharma, Inc.'s other operating expenses?
- Over 2 years (2023 to 2025), ArriVent BioPharma, Inc.'s other operating expenses has grown at a 54.3% compound annual growth rate (CAGR), from $74.59M to $177.53M.
- What does other operating expenses mean?
- Residual operating expenses not classified into specific categories, serving as a catch-all for miscellaneous operating costs.